For most individuals, however, insertion is scheduled for a follow-up visit, usually four to six weeks after birth. The systemic exposure of an infant to the progestin from Kyleena is orders of magnitude lower than what is seen with progestin-only pills (the mini-pill), which are also considered safe during lactation.
Hormone Transfer and Milk Supply: Understanding Kyleena's Impact on Breastfeeding Infants
Safety for the Infant The transfer of levonorgestrel into breast milk is considered minimal. Furthermore, because levonorgestrel is poorly absorbed orally, even if an infant were to ingest the hormone via milk, the amount that would be absorbed into the infant's bloodstream is negligible.
The Impact of Hormones on Milk Supply A primary concern for breastfeeding parents is any potential interference with milk production. This makes it a suitable option for those who wish to continue nursing without switching to alternative feeding methods.
Hormone Transfer and Milk Concentration Findings from Kyleena Studies
Current research and clinical guidelines do not indicate any negative long-term effects on infant growth, development, or health due to exposure through breastfeeding. This localized action is the foundation for its generally favorable safety profile during lactation, as less hormone enters the maternal circulation and, consequently, less is available to pass into breast milk.
More About Kyleena and breastfeeding
Looking at Kyleena and breastfeeding from another angle can help expand the discussion and give readers a second clear paragraph under the same section.
More perspective on Kyleena and breastfeeding can make the topic easier to follow by connecting earlier points with a few simple takeaways.
